GGrantIndex
Sort

39,280 grants matching leukemia

Novel Strategies to Target Leukemia-Stromal Interactions

$366,000
Peng Huang · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · CA

Mechanisms of targeting oncoprotein SET in tumor suppression

$366,000
Wei Gu · Columbia University Health Sciences · R01 · FY2017 · CA

Estimating the Cost Trajectories and Projecting the Cost of Cancer Care in the United States: Methodology and Application

$366,000
Liang Li · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA

Mechanisms of targeting oncoprotein SET in tumor suppression

$366,000
Wei Gu · Columbia University Health Sciences · R01 · FY2018 · CA

Estimating the Cost Trajectories and Projecting the Cost of Cancer Care in the United States: Methodology and Application

$366,000
Liang Li · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA

Role of GAS41 in human cancer

$366,000
Xiaobing Shi · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA

The structural function of ATR in development, oncogenesis and cancer therapy

$366,000
Shan Zha · Columbia University Health Sciences · R01 · FY2017 · CA

Off-the-shelf engineered NK cells for the treatment of AML

$366,000
Katy Rezvani · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA

Personalized therapy for AML patients with a newly identified genetic alteration

$366,000
Sean M Post · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA

Genetic Approaches to Enhance the Anti-Tumor Functions of T Lymphocytes

$365,930
Michel Sadelain · Sloan-Kettering Inst Can Research · P01 · FY2009 · CA

Mechanism of Transcript Elongation in Chromatin by RNA Polymerase II

$365,925
Vasily M Studitsky · Research Inst Of Fox Chase Can Ctr · R01 · FY2014 · GM

Mechanism of Transcript Elongation in Chromatin by RNA Polymerase II

$365,925
Vasily M Studitsky · Research Inst Of Fox Chase Can Ctr · R01 · FY2015 · GM

Notch 1 Regulation of T-ALL Genomes

$365,826
Jon C Aster · Brigham And Women'S Hospital · P01 · FY2012 · CA

The NF-kB signaling system as a regulator of B-cell activation

$365,809
Alexander Hoffmann · University Of California, San Diego · R01 · FY2011 · AI

NEURON SURVIVAL IN CHAGAS DISEASE

$365,800
Tufts University Boston · R01 · FY2000 · NS

Signaling and Metabolic Control in the Drosophila Eye

$365,750
Utpal Banerjee · University Of California Los Angeles · R01 · FY2013 · EY

Adipocytes are Important Players in the Acute Lymphoblastic Leukemia Microenvironment

$365,749
Steven David Mittelman · University Of California Los Angeles · R01 · FY2020 · CA

Pre-Clinical Development of Nuclease Mediated Gene Therapy for SCID

$365,731
Matthew H Porteus · Stanford University · R01 · FY2013 · AI

The Function of Tribbles in the Pathogenesis of AML

$365,595
Warren S Pear · University Of Pennsylvania · P01 · FY2011 · CA

Hoxa9, Meis1, and Pbx in Self-renewal and Leukemogenesis

$365,531
Mark P Kamps · University Of California, San Diego · R01 · FY2012 · CA

Transforming Growth Factor beta in T-Cell Homeostasis and Tolerance

$365,528
Thomas Doetschman · University Of Arizona · R01 · FY2009 · AI

Investigating the role of KAT6A in MLL-rearranged acute myeloid leukemia

$365,525
Mario Andres Blanco · University Of Pennsylvania · R01 · FY2023 · CA

A Bedside Relational Agent to Improve Hematopoietic Cell Transplantation Outcomes in Cancer Patients

$365,505
Victor Wang · Friendi.Fi Corporation · R44 · FY2025 · CA

Diet and Alcohol Induced Epigenetic Changes in Oral Cavity Carcinogenesis Model

$365,496
Lorraine J Gudas · Weill Medical Coll Of Cornell Univ · R01 · FY2011 · AA

Degrading therapeutically important kinases using small molecules

$365,491
Nathanael Schiander Gray · Dana-Farber Cancer Inst · R01 · FY2021 · CA